NYU Langone Health Listed a New Clinical Trial to Study Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

  • Dan Vlad Iosifescu

Press/Media

Period5 Mar 2021

Media coverage

1

Media coverage

  • TitleNYU Langone Health Listed a New Clinical Trial to Study Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date5/03/21
    PersonsDan Vlad Iosifescu
View all 1
View less